Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Introducing the ‘Better Quality, Better Serviced” Video Conferencing Platform

(Click image to play video) Simplified video conferencing across any device means exceptional usability. Enhanced security settings ensure continuous meeting time, encryption, role-based security and password protection. Introducing Fuzion – providing one integ...
Dave Jackson | November 26, 2020 |

Target Price Raised on 'One of the Highest-Quality Stories' in Oil & Gas

The changes made and the reasons for them are detailed in a Raymond James report. In an Oct. 8 research note, analyst Justin Jenkins reported that Raymond James raised its target price on Phillips 66 (PSX:NYSE) to $120 per share from $117 "on higher conviction in ea...
Streetwise Reports | October 10, 2019 |

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...
Isabella Zavarise | December 22, 2020 |

Aurora Cannabis, EXMceuticals, Tilray - Cannabis development in Portugal

From the street to the clinic. Cannabis had the image of an illegal street drug in most rich countries since the prohibition in the USA in the 1930s. Although cannabis has been used as a medicinal plant for more than 1,000 years, the past decades have been marked by other phar...
Mario Hose | February 4, 2020 |

Medcolcanna Prepares For Recurring Commercial Shipments

An Operational Update for 2021 as The Company Prepares for Recurring Shipments Medcolcanna Organics Inc. (NEO: MCCN), a leading Colombian and globally integrated cannabis company, is providing the following corporate update. Key highlights include: Capacity &...
Featured Submission | January 25, 2021 |

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control

The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. In a July 31 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) presented two posters o...
Streetwise Reports | August 6, 2019 |

Solving the Hemp Extraction Problem created by the US Farm Bill

A CONVERSATION WITH NICK KIMBALL, PRESIDENT AND CEO, CASCADIA EXTRACTS, and AARON WILLIAMS, EXECUTIVE VICE PRESIDENT, CASCADIA EXTRACTS MOTIVATION What was your motivation to enter the hemp market in 2019? KIMBALL : Two years ago, the cannabis market ...
Featured Submission | July 22, 2020 |

A Passion for Cannabis. A Plan for Profit.

(Click image above to play video) Savvy investors and smart consumers can usually detect quality. And, a company’s commitment and passion for attaining it. Sugarbud Craft Growers Corp. ( TSX-V: SUGR , OTC: RLLRF , Forum ) is a Calgary-based...
Dave Jackson | March 13, 2021 |

Two Approvals Underscore Biotech's Pipeline Quality

The green lights and their implications are discussed in an H.C. Wainwright & Co. report. In a Jan. 22 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that the European Commission approved the regimen consisting of Genmab A/S' (GMAB:NASD...
Streetwise Reports | January 30, 2020 |

True Leaf Brands Creates Path to Market for BC Craft Cannabis

Licensed producer True Leaf is zeroing in on an enormous opportunity - capturing consumers from the multi-billion-dollar grey market. Spending on cannabis products in the third quarter of last year reached $824 million (CAD) while unlicensed sales, according to many ...
Stockhouse Editorial | May 27, 2021 |
1 2 3 4 5 6 7 8 9 10 ...